Valuation: Terumo Corporation

Market Cap 3,942B 24.77B 21.4B 20.11B 18.29B 34.38B 2,369B 34.95B 236B 92.11B 1,186B 93.01B 90.99B P/E 2027 *
20.9x
P/E 2028 * 20.6x
Enterprise Value 4,008B 25.19B 21.75B 20.44B 18.59B 34.95B 2,408B 35.53B 240B 93.65B 1,206B 94.56B 92.51B EV / Sales 2027 *
3.19x
EV / Sales 2028 * 2.93x
Free-Float
97.07%
Yield 2027 *
1.4%
Yield 2028 * 1.53%
1 day+0.71%
1 week-9.91%
Current month-1.72%
1 month+3.48%
3 months+17.24%
6 months-2.53%
Current year-1.52%
1 week 14.22
Extreme 14.22
16.81
1 month 13.04
Extreme 13.04
16.81
Current year 12.08
Extreme 12.08
16.81
1 year 12.08
Extreme 12.08
19.6
3 years 12.08
Extreme 12.08
21.22
5 years 12.08
Extreme 12.08
25.26
10 years 8.48
Extreme 8.475
25.26
Manager TitleAgeSince
Chief Executive Officer 62 2024-03-31
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 68 2022-03-31
Director/Board Member 63 2019-06-20
Director/Board Member 75 2020-06-24
Change 5-day change 1-year change 3-year change Capi.($)
+0.71%-9.91% - - 24.25B
-0.02%+3.19%-13.95%+4.85% 193B
+0.76%+4.72%-0.77%+9.75% 116B
+1.43%-2.07%+6.43%+67.25% 59.16B
+0.32%+3.92%+38.42%+65.14% 55.75B
+0.79%+3.70%-5.95%-35.11% 49.57B
-1.89%+5.90%+12.24%-22.47% 34.52B
+0.45%+1.45% - - 31.22B
+0.94%-1.31%+41.93%-12.62% 24.36B
+1.98%+12.62%-2.80%+25.91% 24.25B
Average +0.55%+3.69%+9.44%+12.84% 65.26B
Weighted average by Cap. +0.43%+3.41%+1.49%+13.45%

Financials

2027 *2028 *
Net sales 1,255B 7.89B 6.81B 6.4B 5.82B 10.95B 754B 11.13B 75.02B 29.33B 378B 29.62B 28.98B 1,336B 8.39B 7.25B 6.81B 6.2B 11.65B 803B 11.84B 79.83B 31.21B 402B 31.52B 30.83B
Net income 186B 1.17B 1.01B 949M 863M 1.62B 112B 1.65B 11.12B 4.35B 55.99B 4.39B 4.29B 191B 1.2B 1.04B 975M 887M 1.67B 115B 1.69B 11.42B 4.47B 57.52B 4.51B 4.41B
Net Debt 65.54B 412M 356M 334M 304M 572M 39.39B 581M 3.92B 1.53B 19.72B 1.55B 1.51B -24.64B -155M -134M -126M -114M -215M -14.81B -218M -1.47B -576M -7.41B -581M -569M
Logo Terumo Corporation
Terumo Corp is a Japan-based company mainly engaged in the manufacture and sale of medical devices and pharmaceuticals. The Company operates in three segments. The Cardiovascular Company segment provides guidewires for angiography, catheters for angiography, introducer sheaths, coils, stents and bag embolization devices for treatment of cerebral aneurysms, artificial lungs and artificial heart-lung machines. The Medical Care Solutions Company segment provides hospital care solutions, life care solutions, and pharmaceutical solutions. The Blood and Cell Technology Company segment provides blood bags, component blood collection systems, automated blood product systems, pathogen reduction systems, and centrifugal blood component separators.
Employees
30,591
Date Price Change Volume
26-08-14 US$16.67 +1.83% 127,188
26-08-13 US$16.37 +0.24% 45,016
26-08-12 US$16.33 -.--% 71,303
26-08-11 US$16.33 +0.68% 46,941
26-08-10 US$16.22 +2.33% 59,382
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
2,672.50JPY
Average target price
3,106.15JPY
Spread / Average Target
+16.23%

Quarterly revenue - Rate of surprise